Monthly Archives: October 2010

GlaxoSmithKline Accuse of Selling Tainted Product; Settles for $750 Million

The big news in the pharmaceutical world this week is GlaxoSmithKline’s $750 million settlement for selling tainted products.  I first heard about it from the New York Times.  It especially touched a nerve for me, because working in the customer service department of ProgressiveRX, I talk with a lot of people who are nervous about ordering medications that were manufactured in India.

It’s kind of scary when we see these stories in the news.  Most media outlets spend a lot of time trying to convince consumers that the only way to obtain safe medications is through purchasing brand names or approved generics via your local pharmacy.  On the other hand, we’ll get the occasional stories about a brand-name manufacturer having to pay millions of dollars in fines to the FDA for some violation or another (check out the NY Time’s side graphic of the largest settlements between drug makers and the government).

What do stories like this bring up for you?  Do they make you more distrustful of the message that only brand names are safe to consume, or do they make you more nervous about purchasing medications in general, from any source?

Tagged , , , , ,

Weekly Round-Up – 10/22/2010

On Fridays, we post a collection of links on articles related to health care and medication.  Please share in the comments your top finds for the week!

Hat Tip to Dr. Stephen Meyers (aka the MedSavingsDoc) for bringing this Wall Street Journal article to our attention  It examines the growing trend of what pharmacies call “abandonment.”  When patients call to fill orders at a pharmacy, upon returning to pick up the prepared medications, they sometimes find that the cost is much higher than they had anticipated—often, a few hundred dollars higher.  If they decide they can’t afford it (or they’d rather save their money by calling ProgressiveRX) they “abandon” the order.  I think it’s very interesting how they choose the word “abandonment” to describe this phenomenon, with its connotations of obligation, irresponsibility, and some kind of failure on the patient’s part.  Why aren’t pharmacies up-front about the cost of the medication, so the patient isn’t rudely surprised after the order has been prepared?  Perhaps they are counting on the convenience (“I might as well just get it; I really need it now”) or some kind of guilt to persuade the customer to fork over the cash, instead of taking their business to a more reasonably priced source.  (Ahem.  Hint, hint.)

However, I did learn about the HealthWell Foundation from this article. They are a non-profit organization that “that is committed to addressing the needs of individuals with insurance who cannot afford their copayments, coinsurance, and premiums for important medical treatments. Our vision is to ensure that no patient goes without health care because they cannot afford it.” Well, that’s the same as our vision, and we are really glad to hear that this organization exists. Unfortunately, they’re not able to help with medications for ALL conditions: check their Disease list to see if they might be able to help you.

And over at Time Goes By, Ronnie Barrett examines the ramifications of Social Security’s recent announcement that there will be no COLA (or cost-of-living adjustment, for inflation) in 2011. She also links to a site where you can petition Congress to provide seniors with a lump-sum “relief” payment, similar to the $250 checks the government issued last year. Click here to sign the petition.

That’s all we have for today. Have a great weekend, and be sure to check back on Wednesday for our next post!

Tagged , , ,

Heartburn can Cause Esophegeal Cancer

Generic Prilosec, which treats heartburn, is one of our top sellers at ProgressiveRx.  The National Institute of Diabates and Digestive and Kidney Diseases has found that 60 million Americans have heartburn at least once a month, and 15 million suffer from it daily.  So we thought you all would be interested in an article over at Time Goes By which reveals the link between acid reflux and cancer.

Time Goes By is a great blog that reports on “every aspect of aging: health and medical issues, ageism and age discrimination, media, technology, politics and public policy, culture, marketing to elders, the importance of language, love and sex, friendship, post-career careers, retirement, family, the prospect of death and, certainly, humor.”  It is one of those blogs that you can rely on to teach you something new every day.  I certainly appreciate the perspective the writers bring to discussions of today’s issues, and I hope you will, too!

Tagged , , ,

Weekly Round-Up – 10/15/10

On Fridays, we post a collection of links on articles related to health care and medication.  This week, our topic is Medicare and its infamous “Donut Hole.”  Please share in the comments your top finds for the week!

  • From Q1 Medicare, more answers to your questions about the Donut Hole
  • An article from Black Voice News about Congress’s plan to close the gap
  • On Bloomberg.com, more details about the negotiation to offer a 50% discount on brand name medications to those affected by the coverage gap
  • From the LA Times, information about the Medicare Donut Hole in an easy-to-read, Q&A format
  • The NY Times offers a navigation guide for those who have yet to enroll in Medicare for next year

To get information about your coverage, or changing insurance plans, call your State Health Insurance Assistance Program at 1-800-MEDICARE (1-800-633-4227) or visit http://www.medicare.gov.  To find out if you qualify for extra assistance, contact the Social Security Administration at 1-800-772-1213 (TTY users should call 1-800-325-0778). Or, call your local office on aging or visit http://www.eldercare.gov.

And of course, you can always call us here at ProgressiveRX (1-800-400-0707) to find out how much you can save on the prescriptions you need, regardless of your insurance plan.

That’s all we have for today.  Have a great weekend, and be sure to check back on Wednesday for our next post!

Tagged , , , , ,

What is the Medicare “Donut Hole”?

There’s been a lot of buzz in the news these past few weeks about our government’s plan to close the gap in Medicare Part D’s prescription medication coverage. So I thought we’d use today’s article to figure out what it means, exactly, to be in the infamous “donut hole.”

Sadly, not this.

If you choose to get prescription coverage under Medicare Part D, you may eventually find yourself in the ‘coverage gap.’ Here’s how that works:

If you get your prescriptions through this insurance program, you generally pay, on average, 25% of your medication costs, plus a deductible. However, after the total cost of your drugs (at retail price) reaches $2830, Medicare stops coverage. You’re on your own, until you’ve spent so much on your medications that you qualify for “Catastrophic Drug Coverage.” The dollar amounts for how much you have to spend before you qualify (as well as before you hit the maximum coverage limit) can change annually, but for 2010, you have to spend an additional $3610 out-of-pocket before you’ve made it across the donut hole and back to the donut, per se. In the “CDC” phase, you are only responsible for 5% of your drug costs for the rest of the calendar year– sweet, indeed!

Getting through that middle stretch, however, is the tough part. But with the passing of the new health laws, the government has laid out a plan to close the gap.

How to Make a Donut Hole Disappear

This summer, they began sending out $250 rebate checks to seniors who found themselves without coverage. The next step in the plan is to finalize a major-money saving deal with Big Pharma. The government just recently allowed the public to get a look at the details of their negotiations with Big Pharma companies like Pfizer, AstraZeneca, and Bristol-Meyers Squibb. The ultimate goal is to secure a 50% discount on brand-name medication drugs for Medicare beneficiaries when they’re in the donut hole.

Finally, the government will begin subsidizing the drug costs of citizens in the donut hole. It looks like they will begin this program in 2013 by covering 2.5% of the price of brand name medications. They will increase the subsidy until 2020, when it will encompass 25% of the cost of branded drugs. The government has a similar plan for subsidizing generic drugs. The ultimate goal is to subsidize 75% of the costs of generic medications by 2020. Between industry-wide discounts and government subsidies, by 2020, seniors who find themselves in the Medicare donut hole will receive help with up to 75% of the costs of their medications.

What to Do Until 2020

In the meantime, check out ProgressiveRX for high-quality medications that are often up to 80% off the price of their brand-name counterparts at your local pharmacy. Thousands of people have turned to ProgressiveRX so they could continue to get the medication they needed at a price they could afford, even without any help from insurance.

Don’t forget to check back here on Friday for a round-up of links for more information about the Medicare donut hole, the new health legislation, and where you can get help navigating your Medicare plan. To have the post delivered to your inbox, sign up for an email subscription over at the top right side of the page, directly underneath our logo.

How about you? Have you or your loved ones ever had to go through the Medicare donut hole? Are you in it right now? Share your story in the comments!

Tagged , , ,

Weekly Round-Up – 10/1/10

On Fridays, we post a collection of links on articles related to health care and medication.  Please share in the comments your top finds for the week!

  • Dr. Stephen Meyers, the MedSavingsDoc,, demonstrates that sometimes you can save more money by buying medication in smaller quantities. Counter-intuitive, yet valuable, advice!
  • Over at Time Goes By, Saul Friedman writes about Dr. Frances Kelsey, whose struggle to prevent thalidomide from entering the American market led to the creation of the Federal Food, Drug, and Cosmetic Act in 1938. Her story has it all, really: a big corporation trying to hush up the adverse side effects of their new product, a lone scientist searching for the truth, and a plucky reporter who scoops the scandal on the front page. In the end, Congress passes a new law and America is safe once again.
  • The Canada Drugs Blog has posted a review of the AARP’s annual report on the average costs of brand-name medication in the United States.  No surprises here – it looks like prices are rising across the board.

That’s all we have for today.  Have a great weekend, and be sure to check back on Wednesday for our next post!

Tagged , , ,